FDA Authorizes First Serology Test That Detects COVID-19 Neutralizing Antibodies

The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for GenScript USA Inc.'s "cPass SARS-CoV-2 Neutralization Antibody Detection Kit" as the world's first serology test that detects neutralizing antibodies (NAbs) from recent or prior SARS-CoV-2 infection.